Form D · Biotechnology
Larmor Biosystems, Inc.
Aliso Viejo, CA · CIK 0002051755
Offering snapshot reported Jan 14, 2025 · SEC filing
- Reported sold
- $242K Offering amount: $500K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 13, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 14, 2025 | Initial | $242,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-535202
Simple Agreement for Future Equity
Source: Form D, filed Jan 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Gleason | Executive |
| Andrew Mullin | Director |
| Rodolfo Rohr | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
65 Enterprise
Aliso Viejo, CA, 92656
Aliso Viejo, CA, 92656